Replies to post #148986 on Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

Lasers, physicians tend to be fiscally conservative, but despite the fact that ELTP trades OTC, many of my hospital colleagues across multiples specialties have joined me as Elite shareholders. Not surprisingly, there has been an especially enthusiastic response from the Emergency Department. Those docs are on the front lines in the war against diversion of prescription narcotics, and they are daily witnesses to the adverse effects of prescription drug abuse. They understand that at some point in the near future, every prescription written for an opioid painkiller will be an ADT-opioid, and they know that Elite's modular tech will allow doctors to choose whichever opioid agonist is the most appropriate for their patient.

[WeeZuhl]

I can remember sitting in a Pharmacology lecture during my second year of medical school, and the lecturer discussing abuse deterrence by combining agaonist and antagonist in one capsule. This was 10 years before FDA approved Embeda. Brilliant!, I thought.

A few years ago, I was looking for a development stage generic pharmaceutical company, and that's how I found ELTP. At that time, it seemed like their ADT pipeline was a long way off. Now we're literally weeks away from FDA submission. Brilliant!